Methods. In this study, we showed that SsPepO contributes to the human fibronectin-mediated adherence ability of S. suis to human brain microvascular endothelial cells.
Our previous work has demonstrated that SsPepO, which identified a predicted metallo-endopeptidase that shares homology with the M13 peptidase family, contributes to the pathogenesis of S. suis and would be a promising subunit vaccine candidate [26, 27] . However, the function of SsPepO has not been clearly defined. In this study, we report that S. suis binds Fn with higher affinity than other ECM proteins. We characterized the role of SsPepO in both the human Fn (hFn)-mediated adherence and traversal ability of S. suis across HBMECs. Furthermore, we found that the SsPepO-hFn-integrin interaction significantly increased the permeability of the BBB. Finally, we comfirmed that SsPepO contributes to BBB penetration and the development of S. suis meningitis in vivo. Taken together, these results demonstrate that SsPepO, as an Fn-binding protein, plays a role in the development of S. suis meningitis.
MATERIALS AND METHODS

Bacterial Strains, Culture Conditions, Primers, Plasmids, and Cell Lines
The bacterial strains, primers, and plasmids used in this study are listed in Table 1 . Streptococcus suis was grown in either tryptic soy broth (Difco Laboratories) or on tryptic soy agar ([TSA] Difco Laboratories) supplemented with 10% (vol/vol) newborn bovine serum and 50 μg/mL spectinomycin (spc) at 37°C. Escherichia coli strain DH5α (TaKaRa) was grown at 37°C in Luria-Bertani medium supplemented with 100 μg/mL spc or 50 μg/mL ampicillin.
The HBMEC line was established by Professor Kwang Sik (Johns Hopkins University School of Medicine) and shared by Dr. Xiangru Wang (Huazhong Agricultural University) [28, 29] . The HBMECs were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented 10% fetal bovine serum, 10% Nu-serum, 2 mM L-glutamine, 1 mM sodium pyruvate, nonessential amino acids, vitamins, 100 U/mL penicillin, and 100 U/mL streptomycin [30] .
Construction of a Complementation Strain for the SspepO Deletion
The mutant strain ΔSspepO has been constructed by Dr. Chen Tan in our laboratory [26] . The complementation strain CΔSspepO was constructed using the E. coli. S. suis shuttle vector pSET2 as described earlier [31] . The complementation strain CΔSspepO was verified by polymerase chain reaction (Supplementary Figure 1) and sequence analysis (data not shown).
Production of Recombinant SsPepO Protein and Anti-SsPepO
Rabbit Serum
Expression and purification of recombinant protein assays were performed as previously described [27] . After sequence analysis, the resulting plasmids were transformed into E. coli strains BL21 (DE3). The native proteins were expressed by the addition of 1 mM isopropyl β-d-1-thiogalactopyranoside to exponential phase cultures. After another 4-hour incubation at 37°C, the cells were harvested by centrifugation, disrupted by sonication, and clarified by centrifugation. His 6 -tagged proteins were purified by Ni-NTA affinity chromatography (GE Healthcare). The quality and concentrations of purified recombinant proteins were confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and a BCA Protein Assay Kit (Biosharp), respectively. Then, the proteins were stored at −80ºC until use. Polyclonal antiserum against purified SsPepO was raised in rabbits by routine immunogenic procedures using His 6 -tagged SsPepO as antigen, as described previously [16, 32] . Purification of rabbit anti-SsPepO antiserum was performed by affinity chromatography using protein G-Sepharose columns.
Direct Binding Assays
Direct binding assays were carried out as described earlier [33] . 
Streptococcus suis Binding to Immobilized Extracellular Matrix
Streptococcus suis binding to immobilized ECM proteins was performed as described earlier, with some modifications [23, 34] . Microtiter plates were incubated with fibrinogen (Sigma), Fn, plasminogen (Haematologic Technologies), collagen (Sigma), laminin (Sigma), thrombin (Sigma), and casein (0.1 μM per well) overnight at 4°C. Casein was used as a control. The plates were coated with 10 7 colony-forming units (CFUs) of the bacterial suspension and incubated for 1 hour at 37°C. After incubation, free bacteria were removed by washing with phosphate-buffered saline (PBS), and the plates were then incubated by adding 0.25% trypsin-ethylenediaminetetraacetic acid solution (Gibco) for 10 minutes at 37°C. The released bacteria were quantified by appropriate dilutions and palting (Difco Laboratories).
Adhesion of Streptococcus suis to Human Brain Microvascular Endothelial Cells
The adherence ability of S. suis to HBMECs was assessed according to previous procedures with some modifications [35, 36] . The HBMEC monolayers were incubated in medium containing indicated amounts of hFn for 1 hour at 37°C in 5% CO 2 . Then, bacteria were added to the HBMEC monolayers grown in 24-well plates at a multiplicity of infection (MOI) of 10:1 to allow adherence at 37°C for 2 hours. Cell were then washed 3 times with PBS to remove unbound bacteria and lysed in 0.1% saponin for 20 minuttes. In specific experiments, before S. suis infection, cells were first blocked with 20 μg/mL anti-Fn antibody (Proteinech) or 50 μg/mL arginine-glycine-aspartic acid (RGD) peptide (Selleck Chemicals) at 37°C [23] . After 30-minute incubation, cells were washed 3 times with PBS, and cell-adherent bacteria were enumerated by appropriate dilutions and plating.
Fluorescent Microscopy
Fluorescent microscopy studies were performed as described earlier, with some modifications [15] . Before infection, HBMEC monolayers on glass coverslips in 24-well culture plates were added with or without exgenous hFn for 2 hours. Prepared wild-type (WT) or ∆SspepO bacteria were added to each well at an MOI of 10:1. After 2 hours of incubation at 37°C, free bacteria were removed by gently washing 3 times with PBS. In addition, HBMEC cells were fixed with 4% paraformaldehyde (PFA) and permeabilized with 0.1% Triton X-100. Then, plates were stained with swine anti-S. suis polyclonal antibodies (1:1000 dilution in 1% BSA), followed by a sheep anti-swine peroxidase-conjugated antibody (1:10 000 dilution in 1% BSA). Cell monolayers were stained with rabbit anti-hFn polyclonal antibodies (1:1000 dilution in 1% BSA in PBS; Proteinech) followed by a sheep anti-rabbit Alexa Fluor 594-conjugated antibody (1:10 000 dilution in 1% BSA in PBS) or 100 nM rhodamine-labeled phalloidin (Cytoskeleton) for 1 hour at room temperature. Then, the cell monolayers were stained with the fluorescent dye 4' ,6' diamidino-2-phenylindole (Beyotime) and detected using a confocal laser scanning microscope (FV1000; Olympus). CFUs of WT S. suis, ∆SspepO, or C∆SspepO. At 72 hours after injection, mice were euthanized and the blood and brain were collected aseptically and perfused transcardially with PBS. One half of the brain was fixed in 4% paraformaldehyde for histopathological analysis. The remaining brains were homogenized, and the homogenates were plated on TSA plates to determine the bacterial colonies.
Evaluation of Blood-Brain Barrier Permeability
Four groups of female CD1 mice were given injections, via the tail vein, of 2 × 10 8 CFU of WT S. suis, ∆SspepO, C∆SspepO, or PBS, respectively. At 72 hours postinfection, 800 µL Evans blue (EB) solution (1% in PBS) was injected intraperitoneally into the mice-a dye that could not enter into the CNS when the BBB was normal. After 1 hour, all injected mice were anesthetized and perfused transcardially with precooled PBS. Furthermore, brains were removed, photographed, weighed, and homogenized. Then, the EB dye was extracted for the fluorescence reading as previously described [15] . The fluorescence was determined at 620 nm.
Statistical Analysis
Significance of the differences between groups was analyzed with GraphPad Prism software (version 5.0; GraphPad, La Jolla, CA) using a 2-tailed Student t test, one-way analysis of variance, or two-way analysis of variance. P < .05 was considered significant, and P < .01 was considered extremely significant.
RESULTS
Streptococcus suis Binds Immobilized Extracellular Matrix Protein
Previous researchers have indicated that S. suis is capable of binding to ECM proteins [37] . To analyze the ability of S. suis to bind to immobilized ECM proteins, microtiter plates coated with fibrinogen, Fn, plasminogen, collagen, laminin, and thrombin were incubated with the same concentrations of bacterial suspension. As shown in Figure 1 , S. suis binds Fn with higher affinity than other ECM proteins.
SsPepO Binds Fibronectin
To test the binding of SsPepO to Fn, microtiter plates coated with SsPepO were incubated with increasing concentrations of hFn, as described previously. Dose-dependent binding of soluble Fn to immobilized SsPepO was observed (Figure 2A ). In the reverse experiment, binding of SsPepO to immobilized Fn was also detected ( Figure 2B ). Taken together, these data confirmed that SsPepO binds Fn with high affinity.
Binding of SsPepO to Fn Enhances Streptococcus suis
Adherence to Human Brain Microvascular Endothelial Cells
Previous researchers have shown that S. suis serotype 2 is capable of adhering to HBMEC. In this study, we investigated whether hFn could promote S. suis adherence to HBMEC. As shown in Figure 3A , with increasing concentrations of hFn, the adhesion ability of WT S. suis, ∆SspepO, and C∆SspepO to HBMECs increased, but the ratio of adherent cells of the ∆SspepO mutant was significantly lower than that of WT S. suis and C∆SspepO in the addition of hFn. Furthermore, immunofluorescence microscopy ( Figure 3B) found that in the addition of hFn, adherent cells of WT S. suis were significantly more than that of the ∆SspepO mutant assessed by counting bacteria (P < .01). These data indicated that the interaction between SsPepO and hFn promotes S. suis adherence to HBMECs. SsPepO (μg/ml) 500 400 300 200 100 0 Figure 2 . SsPepO binds fibronectin. Microtiter plates were coated with either (A) SsPepO (5 µg/mL) or (B) fibronectin (5 µg/mL), and increasing amounts of fibronectin or SsPepO were added. Binding was detected using specific polyclonal antibodies. Casein was used as a negative control. Data presented are from 3 independent duplicate experiments ± standard deviation. **, P < .01; ***, P < .001. The wells of a microtiter plate were coated with either fibrinogen, fibronectin, plasminogen, collagen, laminin, or thrombin and were then incubated with bacteria. Casein was used as a negative control. The data represents the mean ± standard deviation of 3 independent experiments performed in duplicates.
Role of Integrins in the Interaction Between Streptococcus suis and the Blood-Brain Barrier
To determine that SsPepO-mediated hFn binding accounts for the decreased adherence of the SspepO mutant, each well was incubated with an anti-Fn antibody before infection to interfere with the interaction between S. suis and the host cell surface Fn. The results showed that WT S. suis adherence was significantly inhibited after hFn blockage, whereas adherence Wild-type (WT) S. suis and the ∆SspepO mutant were pretreated with a series of concentrations of hFn before infecting a HBMEC monolayer. The data represent the mean ± standard deviation of 3 independent experiments performed in duplicates. *, P < .05; **, P < .01. (B) The adherent ability of S. suis to HBMECs as evaluated by fluorescent microscopy. The WT S. suis and the ∆SspepO mutant were labeled with fluorescein isothiocyanate (green dye) before infection, and HBMEC monolayers were treated or untreated with Fn (50 µg/mL). F-actin was stained with rhodamine-labeled phalloidin (red), and nuclei were stained with 4',6-diamidino-2-phenylindole ([DAPI] blue). Scale bars, 20 µm. Abbreviation: ns, not significant.
of SsPepO-deficient S. suis remained unchanged ( Figure 4A ). Because integrins are major receptors for ECM components, we next blocked Fn effects by the pretreatment of the RGD peptide sequence, an inhibitor of integrins [17, 19, 38] . To examine whether integrins play an important role in the SsPepO-hBMEC interaction, exogenous RGD peptide was added to block the Fn-binding integrins. Then, the adherent cells of WT S. suis were significantly fewer than that without the addition of RGD peptide ( Figure 4B ).
SsPepO Contributes to the Increased Blood-Brain Barrier
Permeability
Blood-brain barrier breakdown is a crucial step during the development of meningitis caused by bacteria [39, 40] . To evaluate that BBB permeability is enhanced after infection, we measured EB to WT S. suis-, ∆SspepO-, and C∆SspepO-infected mice at 72 hours postinfection. The brains of WT S. suis-and C∆SspepO-infected mice absorbed more EB than the brains of ∆SspepO mutant-infected mice ( Figure 5A ). Evans blue extravasation was assessed quantitatively, which also showed higher levels in the brain lysates from WT S. suisand C∆SspepO-infected mice than from ∆SspepO mutant-infected mice ( Figure 5B ). These results indicated that SsPepO might contribute to BBB disruption during the development of S. suis meningitis.
SsPepO Promotes the Development of Meningitis In Vivo
To analyze the pathogenesis of S. suis CNS infection in vivo, we established a mouse model of S. suis hematogenous meningitis, as showed in (Supplementary Figure 2) . Mice infected with WT S. suis, ∆SspepO, or C∆SspepO were euthanized after 72 hours to analyze bacterial colonization in the brain. The circulating bacterial load of each group was comparable, whereas the bacterial load in the brains of WT S. suis-and C∆SspepO-infected mice was significantly higher than that of ∆SspepO-infected mice ( Figure 6A ). Histologic examination of the brain tissue sections from all of the mice infected with WT S. suis showed the classic features of meningitis, such as neutrophils infiltration, but this was not evident in ∆SspepO-infected mice ( Figure 6C ). The presence of WT S. suis in the brains was observed by Gram staining and immunohistochemical analysis, but the SsPepO-mutant strain was rarely found ( Figure 6B ). Together, these results indicated that SsPepO contributes to the pathogenesis of meningitis.
DISCUSSION
The development of S. suis meningitis involves hematogenous spread and entry into the CNS by crossing the BBB [41, 42] . The adherence ability of S. suis to brain endothelium is a characteristic that likely represents an essential step toward BBB disruption and causing CNS infection [43] . However, the mechanism whereby S. suis adhere to BMEC and gain access to the CNS remains to be elucidated. Binding of S. suis to immobilized Fn has been confirmed, but which adhesins mediate this interaction is also still poorly understood [37] . We further identified a new Fn-binding protein in S. suis, SsPepO, which contributes to the pathogenesis of meningitis by promoting Fn-mediated binding to and penetration of the BBB. Furthermore, our data show that an SsPepO-Fn-integrin interaction is important for S. suis cellular adherence and disease progression.
Fibronectin is an ECM protein involved in several biological processes and may be recognized as a receptor by many bacterial pathogens [22, 44] . In this study, S. suis binding to Fn was higher than other ECM components or to casein, further indicating that Fn-binding proteins may also contribute to S. suis-Fn interactions. In this study, we have shown that SsPepO conferred binding to immobilized Fn. Previous studies show that Fn-binding proteins promote bacterial attachment to the host cells to establish colonization at the beginning of infection [20] . Here, we illustrated that SsPepO binding to Fn significantly increases the adherence of S. suis to HBMEC in vitro, which likely plays a contributing role for the development of S. suis meningitis. Other SsPepO homologues have showed similar phenotypes; for example, pneumococcal protein PepO is an Fn and plasminogen-binding protein that facilitates pneumococcal invasion of host epithelial cells [33] . Furthermore, addition of anti-Fn antibodies could significantly reduce S. suis adhesion, indicating that Fn binding plays an important role in efficient adherence to host cells. Actually, multiple studies showed that Fn is an important ECM component to improve the barrier integrity of the BBB [45] . Furthermore, Fn is a ligand for multiple integrins, especially for the β 1 -integrin family, which belongs to type I transmembrane αβ heterodimers [46, 47] . Via interacting with integrins, Fn plays a role in bridging to integrin-signaling pathways to facilitate bacterial invasion into eukaryotic cells [21] . Fibronectin bridges the meningeal pathogen N meningitidis to α 5 β 1 integrin on the HBMEC surface, promoting bacterial invasion [25] . Binding of Staphylococcus aureus to α 5 β 1 integrin on cells via Fn induces the activation of nuclear factor-κB and the subsequent expression of proinflammatory cytokines in inflammatory macrophages [48] . We also observed that integrins contribute to SsPepO-Fn-mediated S suis adherence to the brain endothelium.
In addition, functional SsPepO plays an important role in the development of meningitis in vivo, because infection with the SspepO mutant led to the decrease of bacterial BBB penetration. In a mouse meningitis model, infection with the ∆SspepO mutant strain resulted in decreased bacterial CNS dissemination and neutrophil infiltration. Furthermore, similar results were showed in a porcine model during S suis infection, where SsPepO was reported contributive to the virulence of S suis [26] . 
CONCLUSIONS
Our results showed that SsPepO binding to Fn facilitated S suis adherence to HBMECs, increasing the permeability of the BBB. Future studies will aim to understand the exact nature of the SsPepO-Fn-integrin interaction on the surface of the brain endothelium. Our study of the role of SsPepO protein in S suis BBB endothelial adherence indicates that therapies targeted at neutralizing this surface molecule could contribute to preventing the development of meningitis induced by S suis.
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